| GSE51254 | GSM1241166 | Illumina HiSeq 2000 | Homo sapiens | Single Cell C1 Microfluidics 13 | colon carcinoma HCT116 | cdna synthesis method: Clontech SMARTer; library construction method: Nextera (transposon); cell line: HCT116 |
| GSE52529 | GSM1269103 | Illumina HiSeq 2500 | Homo sapiens | Cell T24_CT_D12 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 24; debris: FALSE; control well: FALSE; cells in well: 0; library protocol: Single-cell |
| GSE57872 | GSM1396256 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_H06 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
| GSE64016 | GSM1562584 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.276 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
| GSE64016 | GSM1562849 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.071 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
| GSE66357 | GSM1620373 | Illumina NextSeq 500 | Homo sapiens | PS034_R2_0_495 | U87 human glioma cells | cell type: U87 human glioma cells |
| GSE66357 | GSM1620629 | Illumina NextSeq 500 | Homo sapiens | PS034_R2_4_203 | MCF10a human breast cancer cells | cell type: MCF10a human breast cancer cells |
| GSE67835 | GSM1657917 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 47 | hippocampus OPC | tissue: hippocampus; cell type: OPC; age: postnatal 54 years; c1 chip id: 1772078218; experiment_sample_name: AB_S8 |
| GSE67835 | GSM1658173 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 303 | cortex oligodendrocytes | tissue: cortex; cell type: oligodendrocytes; age: postnatal 21 years; c1 chip id: nochipID8; experiment_sample_name: AB_S7 |
| GSE67980 | GSM1660165 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr19.1.3 | lineage-confirmed PCa CTC CRPC progressed on enzalutamide (Group B) | donor: Pr19; donor type: CRPC; enzalutamide: progressed on enzalutamide (Group B) |
